Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Michael Schurr to Anti-Bacterial Agents

This is a "connection" page, showing publications Michael Schurr has written about Anti-Bacterial Agents.

 
Connection Strength
 
 
 
0.447
 
  1. Bogue AL, Panmanee W, McDaniel CT, Mortensen JE, Kamau E, Actis LA, Johannigman JA, Schurr MJ, Satish L, Kotagiri N, Hassett DJ. AB569, a non-toxic combination of acidified nitrite and EDTA, is effective at killing the notorious Iraq/Afghanistan combat wound pathogens, multi-drug resistant Acinetobacter baumannii and Acinetobacter spp. PLoS One. 2021; 16(3):e0247513.
    View in: PubMed
    Score: 0.098
  2. McDaniel CT, Panmanee W, Winsor GL, Gill E, Bertelli C, Schurr MJ, Dongare P, Paul AT, Ko SB, Lau GW, Dasgupta N, Bogue AL, Miller WE, Mortensen JE, Haslam DB, Dexheimer P, Muruve DA, Aronow BJ, Forbes MDE, Danilczuk M, Brinkman FSL, Hancock REW, Meyer TJ, Hassett DJ. AB569, a nontoxic chemical tandem that kills major human pathogenic bacteria. Proc Natl Acad Sci U S A. 2020 03 03; 117(9):4921-4930.
    View in: PubMed
    Score: 0.091
  3. Grover N, Plaks JG, Summers SR, Chado GR, Schurr MJ, Kaar JL. Acylase-containing polyurethane coatings with anti-biofilm activity. Biotechnol Bioeng. 2016 12; 113(12):2535-2543.
    View in: PubMed
    Score: 0.070
  4. Liao J, Schurr MJ, Sauer K. The MerR-like regulator BrlR confers biofilm tolerance by activating multidrug efflux pumps in Pseudomonas aeruginosa biofilms. J Bacteriol. 2013 Aug; 195(15):3352-63.
    View in: PubMed
    Score: 0.057
  5. Pires EM, Pugazhenthi U, Fink MK, Habenicht LM, Fong DL, Leszczynski JK, Schurr MJ, Manuel CA. Antibiotic Treatment of Corynebacterium bovis-associated Clinical Disease in NSG Mice. Comp Med. 2023 Dec 01; 73(6):461-465.
    View in: PubMed
    Score: 0.029
  6. Manuel CA, Johnson LK, Pugazhenthi U, Fong DL, Fink M, Habenicht LM, Leszczynski JK, Diana IR, Schurr MJ, Frank DN. Effect of Antimicrobial Prophylaxis on Corynebacterium bovis Infection and the Skin Microbiome of Immunodeficient Mice. Comp Med. 2022 04 01; 72(2):78-89.
    View in: PubMed
    Score: 0.026
  7. Trivedi R, Gautam D, Kehe GM, Escobedo HD, Patel K, Stansbury JW, Schurr MJ, Nair DP. Synthesis, characterization and evaluation of azobenzene nanogels for their antibacterial properties in adhesive dentistry. Eur J Oral Sci. 2022 02; 130(1):e12832.
    View in: PubMed
    Score: 0.026
  8. Fagre AC, Pugazhenthi U, Cheleuitte-Nieves C, Crim MJ, Henderson KS, Fong DL, Leszczynski JK, Schurr MJ, Daniels JB, Manuel CA. Antimicrobial Susceptibility of Corynebacterium bovis Isolates from Immunodeficient Rodents. Comp Med. 2021 06 01; 71(3):210-214.
    View in: PubMed
    Score: 0.025
  9. Su S, Panmanee W, Wilson JJ, Mahtani HK, Li Q, Vanderwielen BD, Makris TM, Rogers M, McDaniel C, Lipscomb JD, Irvin RT, Schurr MJ, Lancaster JR, Kovall RA, Hassett DJ. Catalase (KatA) plays a role in protection against anaerobic nitric oxide in Pseudomonas aeruginosa. PLoS One. 2014; 9(3):e91813.
    View in: PubMed
    Score: 0.015
  10. Hassett DJ, Sutton MD, Schurr MJ, Herr AB, Caldwell CC, Matu JO. Pseudomonas aeruginosa hypoxic or anaerobic biofilm infections within cystic fibrosis airways. Trends Microbiol. 2009 Mar; 17(3):130-8.
    View in: PubMed
    Score: 0.011
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)